F2G

United Kingdom
Oakhill, England, United Kingdom, M30 0LX

Company profile

F2G company profile

F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease. The Company was founded on its proprietary genomics technology (MycoBank®) that identifies essential gene targets in fungi. Having received initial funding in 2002 the company then rapidly diversified into chemistry-driven discovery. They have also assembled an experienced development capacity.

Business identity

Contact email
[email protected]
Phone number
44 (0)161 785 1270
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
1998-01-01, Year

Headquarters

Postal code
M30 0LX
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
13
Total equity funding
$353.5M
Last funding
Series H / $100M / 2024-09-12
Last equity funding
Series H / $100M
Investors
22
Lead investors
11
Founders
1
Articles
33

Founders and investors

Founders

David Denning

Lead investors

AMR Action FundAstellas Venture ManagementBankInvest Biomedical VentureCowen Healthcare InvestmentsEuropean Investment BankForbion Capital PartnersInnovate UKIntermediate Capital GroupNovartis Venture FundSectoral Asset Management

Investors

European Investment BankForbion Capital PartnersIntermediate Capital GroupNovo HoldingsSofinnova Partners